|
|||||
|
|
Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non‐Small Cell Lung Cancer and the Role of Biopsy at Progression |
|
| Authors: | Mark A. Socinski Liza C. Villaruz Jeffrey Ross |
| Affiliation: | 1. Florida Hospital Cancer Institute, Orlando, Florida, USA;2. University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA;3. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA;4. Foundation Medicine Inc., Cambridge, Massachusetts, USA |
| Abstract: | |
| Keywords: | Gefitinib Erlotinib Afatinib Osimertinib Non‐small cell lung cancer Treatment |